Contact information
Rosie Bradley
BSc, MSc
Medical Statistician
Rosie is a Medical Statistician in the Clinical Trial Service Unit (CTSU). Prior to joining in 2012, she studied Applied Statistics at the University of Plymouth (BSc) and Biometry at the University of Reading (MSc). She is currently involved in randomised trials in neurodegenerative diseases and is working on meta-analyses of breast cancer trials in EBCTCG.
Recent publications
-
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2022), Lancet Oncol, 23, 382 - 392
-
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Journal article
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
-
Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT.
Journal article
Gathercole R. et al, (2021), Health Technol Assess, 25, 1 - 156
-
Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT
Journal article
Howard R. et al, (2020), Efficacy and Mechanism Evaluation, 7, 1 - 62
-
The impact of assistive technology on burden and psychological well-being in informal caregivers of people with dementia (ATTILA Study).
Journal article
Davies A. et al, (2020), Alzheimers Dement (N Y), 6